Citigroup
DRGS

Citigroup’s RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS DRGS Stock Holding History

Citigroup’s Portfolio DRGS Stock Details DRGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-125
Closed -$6K – 7535
2014
Q2 		$6K Buy
+125
New +$5.83K ﹤0.01% 6425

Other funds holding DRGS

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citigroup's DRGS Position: Q3 2014 in Review

Citigroup sold out of RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) in Q3 2014, closing a stake of 125 shares — an estimated $6K sold.

Citigroup first reported a position in DRGS in Q2 2014 and held it in 1 quarter. The position peaked at $6K in Q2 2014. 4 funds tracked by Wall St. Rank hold DRGS as of Q3 2014.

  • Citigroup reported no remaining RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS position as of Q3 2014 after selling out during the quarter.
  • Citigroup sold 125 RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS shares in Q3 2014, an estimated $6K.
  • Citigroup first reported a position in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS in Q2 2014 and held it in 1 quarter.
  • Citigroup's RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS position peaked at $6K in Q2 2014.
  • 4 funds tracked by Wall St. Rank held RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS as of Q3 2014.

Based on Citigroup's 13F filing for Q3 2014, filed 14 Nov 2014.